Latest News

DKS Investors Have Opportunity to Lead DICK'S Sporting Goods, Inc. Securities Fraud Lawsuit
NEW YORK, Sept. 13, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of DICK'S Sporting Goods, Inc.

Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants
LISRAYA's recent approval gives ROIV a nice commercial foundation, while additional indications could turn brepocitinib into a broader immunology franchise. ROIV's pulmonary asset with mosliciguat is

If I Were Retiring In 2032, This Is What I'd Own
Social Security faces a projected 22% benefit cut by 2032, requiring a 30%+ increase in personal retirement contributions for average Americans. I advocate a diversified, income-focused portfolio with

Everyone Is Avoiding These REITs: That's The Opportunity
Some of the most hated REIT sectors may offer the biggest upside. European REITs trade at unusually steep NAV discounts. Life science and tower REITs could recover as sentiment turns.

Seagate Technology Sees AI Storage Demand Fueling HAMR Growth and Margin Gains
Seagate Technology NASDAQ: STX CFO Gianluca Romano said demand for mass storage is being supported by the early stages of artificial intelligence infrastructure investment, with growth extending from

SpaceX: Taking Flight And Defying Lock-Ups Ahead Of Q4, Communacopia Takeaways
SpaceX is reiterated as a buy, with shares resilient despite volatility and ongoing lock-up expirations. Q2 results showed revenue up 90% to $7.8B and a reduced net loss, with aggressive AI expansion

Nintendo: The Software Payoff Is Still Ahead
Nintendo is rated Buy, driven by its robust software earnings and potential for digital and IP-driven growth. NTDOY's investment thesis centers on recurring software sales, digital expansion, and mone

Kardigan: Funded Precision Cardiology Offers More Than Pipeline Diversification
Kardigan targets genetic DCM, moderate CAVS, and post-hospitalization ASH with differentiated, biology-driven clinical programs. KARD holds $660.7M in liquid assets, providing roughly 2–3 years of run

Wall Street Week Ahead
Wall Street heads into Fed week with Wednesday's interest-rate decision set to dominate trading, as investors await what would be the central bank's first rate increase of the current cycle.

AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears
Astrazeneca NYSE: AZN presented Phase III data for tozorakimab in chronic obstructive pulmonary disease, or COPD, at the 2026 European Respiratory Society Congress in Barcelona, reporting statisticall

Yancoal Australia: A Cash Flow Upgrade Hidden By Weak Reported Earnings
Yancoal Australia is upgrading portfolio quality by acquiring Kestrel and closing Ashton, focusing on operational cash generation over reported earnings. YACAF trades at a significant EV/EBITDA discou

Dell: Powerhouse AI Stock
Dell Technologies has transformed into a mission-critical supplier for the global AI rollout, achieving record highs and justifying its momentum with robust fundamentals. ISG revenue surged 89% year-o

I visited Capital One's lounge at LaGuardia. I loved the free steak and shrimp, but I'll do 1 thing differently next time.
Business Insider editor Jane Zhang utilized Capital One's lounge at LaGuardia Airport ahead of her flight home. Thanks to lounge access through her credit card, she enjoyed tapas, steak, shrimp, and m

Datadog Conference: CEO Says AI and Enterprise Growth Are Accelerating
Datadog NASDAQ: DDOG CEO and Founder Olivier Pomel said the company is seeing accelerating growth across both AI-focused customers and its broader enterprise customer base as organizations expand clou

UNCY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Unicycive To Contact Him Directly To Discuss Their Options If you purchased or acquir

BZAI INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Blaize Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Blaize To Contact Him Directly To Discuss Their Options If you purchased or acquired

BBNX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you purchased or acq

HDB INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds HDFC Bank Limited Investors of Securities Class Action Lawsuit Deadline on October 12, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In HDFC Bank Limited To Contact Him Directly To Discuss Their Options If you purchased o

Booking CEO Details AI-Powered Connected Trip Strategy at Global TMT Conference
Booking NASDAQ: BKNG CEO and Director Glenn Fogel outlined the online travel company's priorities around artificial intelligence, its Connected Trip strategy, loyalty programs, alternative accommodati

AVEX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds AEVEX Investors of Securities Class Action Lawsuit Deadline on October 20, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AEVEX To Contact Him Directly To Discuss Their Options If you purchased or acquired s